Department of Anesthesiology, Yale School of Medicine, New Haven, CT.
Anesthesiology Institute, Cleveland Clinic Foundation, Cleveland, OH.
Mayo Clin Proc. 2022 Feb;97(2):397-416. doi: 10.1016/j.mayocp.2021.11.011.
There is a lack of guidelines for preoperative management of psychiatric medications leading to variation in care and the potential for perioperative complications and surgical procedure cancellations on the day of surgery. The Society for Perioperative Assessment and Quality Improvement identified preoperative psychiatric medication management as an area in which consensus could improve patient care. The aim of this consensus statement is to provide recommendations to clinicians regarding preoperative psychiatric medication management. Several categories of drugs were identified including antidepressants, mood stabilizers, anxiolytics, antipsychotics, and attention deficit hyperactivity disorder medications. Literature searches and review of primary and secondary data sources were performed for each medication/medication class. We used a modified Delphi process to develop consensus recommendations for preoperative management of individual medications in each of these drug categories. While most medications should be continued perioperatively to avoid risk of relapse of the psychiatric condition, adjustments may need to be made on a case-by-case basis for certain drugs.
对于精神科药物的术前管理,目前缺乏指导原则,这导致了护理的差异,以及手术当天出现围手术期并发症和手术取消的可能性。围手术期评估和质量改进协会将术前精神科药物管理确定为可以提高患者护理的共识领域。本共识声明的目的是为临床医生提供有关术前精神科药物管理的建议。确定了几类药物,包括抗抑郁药、心境稳定剂、抗焦虑药、抗精神病药和注意缺陷多动障碍药物。对每种药物/药物类别进行了文献检索和主要及次要数据源的审查。我们使用改良 Delphi 法为这些药物类别中的每种药物制定了术前管理的共识建议。虽然大多数药物应在围手术期继续使用,以避免精神疾病复发的风险,但某些药物可能需要根据具体情况进行调整。